Analizar a los pacientes con microcarcinoma papilar (MCP) de tiroides para intentar establecer su pronóstico al diferenciar los diagnosticados pre y postoperatoriamente.
Pacientes Y métodoEstudio retrospectivo de 83 pacientes con MCP, estableciendo dos grupos en función del momento del diagnóstico. Se compararon su clínica, histología y seguimiento, y se analizaron la supervivencia y el intervalo libre de enfermedad (ILE) entre los dos grupos.
ResultadosEl grupo A (pacientes diagnosticados preoperatoriamente) incluyó a 30 pacientes (36,1%) y el grupo B (de diagnóstico postoperatorio) a 53 (63,9%). Se detectó recurrencia en 5 pacientes, todos del grupo A. La supervivencia global fue del 98,8% y el ILE global del 94% (83,3% para el grupo A y el 100% para el B, con diferencias significativas; p = 0,01).
ConclusionesEs útil separar a los pacientes con MCP de tiroides diagnosticados pre o postoperatoriamente, ya que su evolución es diferente y, por lo tanto, requieren un tratamiento y seguimiento diferente.
We aimed to analyze patients with papillary thyroid microcarcinoma (PTM) in order to establish the prognosis according to the differences observed between those diagnosed before surgery and those diagnosed postoperatively.
Patients And MethodRetrospective study of 83 PTM patients who were distributed in 2 groups. Clinical, histological and follow-up data were compared. Survival and disease-free interval (DFI) were analyzed in both groups.
ResultsGroup A (diagnosed before surgery): 30 patients (36.1%); group B (diagnosed postoperatively): 53 patients (63.9%). Five group A patients had a relapse. Overall survival was 98.8% and overall DFI was 94% (83.3% in group A and 100% in group B, p = 0.01).
ConclusionsIt is useful to differentiate patients with PTM diagnosed before surgery from those whose PTM was diagnosed after since their evolution is different.